Real-World Study on the Treatment of Macular Edema in Central Retinal Vein Occlusion Using Traditional Chinese Medicine (TCM) and Its Medication Guidelines

Zi-Yang Chen, Hang Yuan, Xiaoyan Zhang, Li-Ke Xie, X. Hao
{"title":"Real-World Study on the Treatment of Macular Edema in Central Retinal Vein Occlusion Using Traditional Chinese Medicine (TCM) and Its Medication Guidelines","authors":"Zi-Yang Chen, Hang Yuan, Xiaoyan Zhang, Li-Ke Xie, X. Hao","doi":"10.53388/dct20230014","DOIUrl":null,"url":null,"abstract":"Object: The aim is to evaluate how effective Traditional Chinese Medicine (TCM) is in treating patients who have central retinal vein occlusion with macular edema (CRVO-ME) in a real-world study. Furthermore, the objective of the research was to examine the TCM prescription trends in the management of CRVO-ME. Method: A single-center real-world study (RWS) was carried out over a span of 19 years, following the established design. The study encompassed 113 patients diagnosed with CRVO-ME. Out of these, 74 patients received TCM treatment, while the remaining individuals underwent a combined therapy involving TCM and anti-VEGF drugs through intravitreal injection. The patients were matched using propensity score matching (PSM). The result measured in the RWS was BCVA. The oral prescriptions for CRVO-ME that led to observable and effective outcomes were collected. Excel and the TCM Inheritance Auxiliary Platform V2.5 were utilized to optimize mutual information, hierarchical clustering based on entropy, and other techniques to extract medication regulations and features. Result: After applying PSM, each group comprised 29 cases. Both groups exhibited improved BCVA following treatment; however, there was no statistically significant distinction in BCVA or effectiveness between the two groups (all P > 0.05). Apart from the analysis of oral prescriptions for CRVO-ME, the investigation pinpointed the most frequently used TCMs, namely Flos Carthami, Semen Persicae, Radix Angelica sinensis, Radix Rehmanniae, and Radix et Rhizoma Notoginseng. Frequently utilized medications tended to possess cold, warm, or mild attributes and exhibited a taste profile that was either bitter or sweet. The primary meridians associated with the medicines employed in treating CRVO-ME were liver, spleen, stomach, heart, and lung. Through the application of association rule analysis, it was discerned that there were 195 commonly employed combinations of medicines. Additionally, a complex system entropy cluster analysis unveiled 13 key combinations of medicines. By employing an unsupervised entropy hierarchical clustering analysis, a novel prescription was formulated. Conclusion: Within a real-world population of CRVO-ME patients, TCM exhibited its effectiveness. The treatment approach for CRVO-ME predominantly involved the regulation of qi (Qi is an exceedingly subtle substance within the human body, brimming with vitality and ceaseless motion. It constitutes the fundamental element that shapes and sustains the various processes of human life.) and blood as well as the resolution of dampness. The oral prescriptions frequently targeted the meridians of liver, spleen, stomach, heart, and lungs.","PeriodicalId":68926,"journal":{"name":"药物联合治疗","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药物联合治疗","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.53388/dct20230014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Object: The aim is to evaluate how effective Traditional Chinese Medicine (TCM) is in treating patients who have central retinal vein occlusion with macular edema (CRVO-ME) in a real-world study. Furthermore, the objective of the research was to examine the TCM prescription trends in the management of CRVO-ME. Method: A single-center real-world study (RWS) was carried out over a span of 19 years, following the established design. The study encompassed 113 patients diagnosed with CRVO-ME. Out of these, 74 patients received TCM treatment, while the remaining individuals underwent a combined therapy involving TCM and anti-VEGF drugs through intravitreal injection. The patients were matched using propensity score matching (PSM). The result measured in the RWS was BCVA. The oral prescriptions for CRVO-ME that led to observable and effective outcomes were collected. Excel and the TCM Inheritance Auxiliary Platform V2.5 were utilized to optimize mutual information, hierarchical clustering based on entropy, and other techniques to extract medication regulations and features. Result: After applying PSM, each group comprised 29 cases. Both groups exhibited improved BCVA following treatment; however, there was no statistically significant distinction in BCVA or effectiveness between the two groups (all P > 0.05). Apart from the analysis of oral prescriptions for CRVO-ME, the investigation pinpointed the most frequently used TCMs, namely Flos Carthami, Semen Persicae, Radix Angelica sinensis, Radix Rehmanniae, and Radix et Rhizoma Notoginseng. Frequently utilized medications tended to possess cold, warm, or mild attributes and exhibited a taste profile that was either bitter or sweet. The primary meridians associated with the medicines employed in treating CRVO-ME were liver, spleen, stomach, heart, and lung. Through the application of association rule analysis, it was discerned that there were 195 commonly employed combinations of medicines. Additionally, a complex system entropy cluster analysis unveiled 13 key combinations of medicines. By employing an unsupervised entropy hierarchical clustering analysis, a novel prescription was formulated. Conclusion: Within a real-world population of CRVO-ME patients, TCM exhibited its effectiveness. The treatment approach for CRVO-ME predominantly involved the regulation of qi (Qi is an exceedingly subtle substance within the human body, brimming with vitality and ceaseless motion. It constitutes the fundamental element that shapes and sustains the various processes of human life.) and blood as well as the resolution of dampness. The oral prescriptions frequently targeted the meridians of liver, spleen, stomach, heart, and lungs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中药治疗视网膜中央静脉阻塞黄斑水肿的临床研究及用药指南
目的:评价中药治疗视网膜中央静脉阻塞合并黄斑水肿(CRVO-ME)的临床疗效。此外,本研究的目的是探讨中医处方在CRVO-ME治疗中的趋势。方法:采用单中心真实世界研究(RWS),历时19年,遵循既定设计。该研究包括113例诊断为CRVO-ME的患者。其中,74名患者接受了中药治疗,其余患者通过玻璃体内注射接受了中药和抗vegf药物的联合治疗。采用倾向评分匹配(PSM)对患者进行匹配。RWS测定结果为BCVA。收集可观察到有效疗效的CRVO-ME口服处方。利用Excel和中医传承辅助平台V2.5优化互信息、基于熵的分层聚类等技术提取用药规律和特征。结果:经PSM治疗后,每组29例。两组治疗后BCVA均有所改善;但两组在BCVA及疗效方面差异无统计学意义(P < 0.05)。除了对CRVO-ME的口服处方进行分析外,调查还确定了最常用的中药为红花、桃子、当归、地黄和三七。经常使用的药物往往具有冷、热或温和的属性,并表现出苦或甜的味道特征。治疗CRVO-ME的主要经络为肝、脾、胃、心、肺。通过关联规则分析的应用,发现有195种常用的药物组合。此外,一个复杂的系统熵聚类分析揭示了13种关键的药物组合。采用无监督熵层次聚类分析,提出了一种新的处方。结论:在CRVO-ME患者的真实人群中,中医药显示出其有效性。CRVO-ME的治疗方法主要涉及气的调节(气是人体内非常微妙的物质,充满活力和不断运动。它构成了塑造和维持人类生命和血液的各种过程的基本元素,以及解决潮湿的问题。口服方剂常针对肝、脾、胃、心、肺经络。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
42
期刊最新文献
“Astragali Radix - Salviae Miltiorrhizae Radix Et Rhizoma” herb pair in the treatment of liver cirrhosis and its pharmacological mechanisms Exploring the mechanism of Guizhi decoction’s “Jun-Chen-Zuo-Shi” in treating plant nervous disorders based on weighted network pharmacology and molecular docking techniques Effect of cerebralcare granule® combined with donepezil on Alzheimer’s disease Mechanism of action of Zhishi Daozhi decoction in the treatment of diarrhea based on network pharmacology and molecular docking Comment on“mechanisms of compound Kushen injection for treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1